SynthesisInternal medicine (Tokyo, Japan)2026
Therapeutic Impact of Third-generation Tyrosine Kinase Inhibitors on Lung Squamous Cell Carcinoma with Epidermal Growth Factor Receptor Mutations: A Case Description and Systematic Literature Review.
Naoto Minematsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.